Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Crohn's Disease Health Center

Font Size

Remicade Puts Crohn's Disease Into Remission

WebMD Health News

Oct. 22, 2001 -- A few years ago, Remicade brought good news to the world of Crohn's disease, which wreaks havoc on the bowels. And now, new research is showing that when given every few weeks, Remicade injections can actually keep people in remission.

In the past, Crohn's disease, which affects a half a million people in the U.S., was treated when symptoms flared up, such as diarrhea, abdominal pain, weight loss, and fever. But now, Remicade has the potential to change all that.

"For the first time, doctors will be able to move beyond treating flare-ups to actually managing the disease over time," lead investigator Stephen B. Hanauer, MD, professor of medicine at the University of Chicago, says in a news release. This will hopefully allow people with Crohn's to go about their day without constantly worrying when the next attack will occur.

Hanauer and colleagues looked at 573 people with moderate to severe Crohn's disease. Each person received a single dose of Remicade, and 58% of them had improvement. The ones who responded favorably to this first injection then received four injections of either placebo or low- or high-dose Remicade over the next 22 weeks.

The researchers then evaluated their progress 30 weeks after the injections were started and found that the people who had received Remicade were twice as likely to be in remission than the people who received placebo.

Remission was seen in 22% of the placebo group, 39% of the low-dose Remicade group, and 45% of the high-dose group.

Remicade works in a novel way, attacking a chemical called tumor necrosis factor alpha, which is thought to be one of the main culprits behind the inflammation of Crohn's disease. Other treatments for this disabling bowel disease are surgery and other medications that can help with symptoms but don't make a big impact on progression of the disease.

Remicade could change the lives of many people with Crohn's disease if it can lessen the characteristic symptom flares and keep people in remission for longer periods of time.

Today on WebMD

butter curls
Foods to avoid.
woman with pains in abdomen
Get personalized tips.
woman in restaurant
Tips for staying active.
Woman suffering from IBD
Learn about Crohn’s, colitis, and more.
Treatment Options For Crohns Disease
butter curls
crohns disease healthcheck
capsules in hand
Trigger Foods To Avoid With Crohns
Exercising When You Have A GI Disorder
Newly Diagnosed With Crohns Steps To Take
When Surgery Might Be Required For Crohns